You are here

Home

Clinical Trials: Lung Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, April 26, 2019 - 12:00
Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for Interstitial Lung Disease in Patients With Connective Tissue Disorders
Conditions:   Interstitial Lung Disease;   Connective Tissue Diseases
Intervention:   Biological: Allogeneic Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs)
Sponsor:   Mayo Clinic
Recruiting
Posted: Wednesday, April 10, 2019 - 12:00
Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)
Conditions:   COPD;   Respiratory Insufficiency
Interventions:   Procedure: Lipoaspiration;   Procedure: AD-cSVF;   Procedure: Normal Saline IV
Sponsor:   Healeon Medical Inc
Not yet recruiting
Posted: Wednesday, March 13, 2019 - 12:00
Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia
Condition:   Bronchopulmonary Dysplasia
Intervention:   Drug: transplantation of hUC-MSCs
Sponsor:   Children's Hospital of Chongqing Medical University
Recruiting
Posted: Thursday, February 28, 2019 - 12:00
A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD
Condition:   Bronchopulmonary Dysplasia
Interventions:   Biological: UNEX-42;   Biological: Phosphate-buffered saline
Sponsor:   United Therapeutics
Not yet recruiting
Posted: Thursday, January 17, 2019 - 12:00
Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome
Condition:   Respiratory Distress Syndrome, Adult
Intervention:   Biological: HLCM051
Sponsor:   Healios K.K.
Recruiting
Posted: Thursday, December 13, 2018 - 12:00
Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia
Condition:   Bronchopulmonary Dysplasia
Interventions:   Drug: Transplantation of hUC-MSCs;   Drug: No transplantation of hUC-MSCs
Sponsor:   Children's Hospital of Chongqing Medical University
Recruiting
Posted: Tuesday, September 25, 2018 - 12:00
The Treatment of Bronchopulmonary Dysplasia by Intratracheal Instillation of Mesenchymal Stem Cells
Conditions:   Safety Issues;   Effect of Drugs
Interventions:   Other: mesenchymal stem cells therapy;   Drug: 0.9% sodium chloride
Sponsor:   Guangdong Women and Children Hospital
Not yet recruiting
Posted: Friday, August 24, 2018 - 12:00
Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)
Condition:   Bronchopulmonary Dysplasia
Interventions:   Drug: Human Umbilical Cord-derived Mesenchymal stem cell;   Drug: placebo
Sponsor:   Children's Hospital of Fudan University
Not yet recruiting
Posted: Wednesday, August 15, 2018 - 12:00
Mesenchymal Stem Cells for The Treatment of Bronchopulmonary Dysplasia in Infants
Condition:   Bronchopulmonary Dysplasia
Intervention:   Biological: Human Umbilical Cord Derived-Mesenchymal Stem Cells
Sponsor:   Meridigen Biotech Co., Ltd.
Not yet recruiting
Posted: Thursday, July 26, 2018 - 12:00
Human Mesenchymal Stem Cells For Refractory Pulmonary Diseases
Condition:   Refractory Pulmonary Diseases
Interventions:   Drug: Transplantation of mesenchymal stem cell;   Drug: No Transplantation of Mesenchymal Stem Cell
Sponsor:   Children's Hospital of Chongqing Medical University
Recruiting

Pages